Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.

Journal of the National Cancer Institute - 1 Oct 2015

Yoon Harry H, Shi Qian, Alberts Steven R, Goldberg Richard M, Thibodeau Stephen N, Sargent Daniel J, Sinicrope Frank A

Abstract excerpt

BACKGROUND: It is unknown if, after controlling for clinicopathologic variables and treatment, racial disparities in colon cancer outcomes persist. Molecular marker analysis in North American patients comparing Asians with other races has not been reported. METHODS: BRAF (V600E) and KRAS mutations were analyzed in node-positive colon cancer patients (n = 3305) treated with FOLFOX-based chemotherapy in an adjuvant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Asian People

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Black People

Share to Colonic Neoplasms

Share to Mutation

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 26160882
DOI: 10.1093/jnci/djv186
PMCID: PMC5758035

Genes

BRAF
KRAS
TTR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.PMID 26160882Read ↗

Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.Semantic proximity Read ↗

KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort.Semantic proximity Read ↗

Racial Differences in Stage IV Colorectal Cancer Molecular Profiling and Mutation Rates.Semantic proximity Read ↗

Variation in KRAS/NRAS/BRAF-Mutation Status by Age, Sex, and Race/Ethnicity Among a Large Cohort of Patients with Metastatic Colorectal Cancer (mCRC).Semantic proximity Read ↗

KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.Semantic proximity Read ↗

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.Semantic proximity Read ↗

Determinants of Black/White Differences in Colon Cancer SurvivalSemantic proximity Read ↗

Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities.Semantic proximity Read ↗

Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.Semantic proximity Read ↗

Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study.Semantic proximity Read ↗

Differential Immune Signatures in the Tumor Microenvironment are Associated with Colorectal Cancer Racial Disparities: A Cohort Study of Biorepository DataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.